A citation-based method for searching scientific literature

Jason M Hoover, Susan M Chang, Ian F Parney. Neuroimaging Clin N Am 2010
Times Cited: 10







List of co-cited articles
99 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.
Walter Stummer, Uwe Pichlmeier, Thomas Meinel, Otmar Dieter Wiestler, Friedhelm Zanella, Hans-Jürgen Reulen. Lancet Oncol 2006
60

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
Roger Stupp, Warren P Mason, Martin J van den Bent, Michael Weller, Barbara Fisher, Martin J B Taphoorn, Karl Belanger, Alba A Brandes, Christine Marosi, Ulrich Bogdahn,[...]. N Engl J Med 2005
60

An extent of resection threshold for newly diagnosed glioblastomas.
Nader Sanai, Mei-Yin Polley, Michael W McDermott, Andrew T Parsa, Mitchel S Berger. J Neurosurg 2011
832
50

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.
M Lacroix, D Abi-Said, D R Fourney, Z L Gokaslan, W Shi, F DeMonte, F F Lang, I E McCutcheon, S J Hassenbusch, E Holland,[...]. J Neurosurg 2001
40

Extent of resection.
Laura B Ngwenya, E Antonio Chiocca. J Neurosurg 2011
10
30

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
Roger Stupp, Monika E Hegi, Warren P Mason, Martin J van den Bent, Martin J B Taphoorn, Robert C Janzer, Samuel K Ludwin, Anouk Allgeier, Barbara Fisher, Karl Belanger,[...]. Lancet Oncol 2009
30

Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme.
Matthew J McGirt, Khoi D Than, Jon D Weingart, Kaisorn L Chaichana, Frank J Attenello, Alessandro Olivi, John Laterra, Lawrence R Kleinberg, Stuart A Grossman, Henry Brem,[...]. J Neurosurg 2009
188
30

A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.
Manfred Westphal, Dana C Hilt, Enoch Bortey, Patrick Delavault, Robert Olivares, Peter C Warnke, Ian R Whittle, Juha Jääskeläinen, Zvi Ram. Neuro Oncol 2003
838
30


Changing paradigms--an update on the multidisciplinary management of malignant glioma.
Roger Stupp, Monika E Hegi, Martin J van den Bent, Warren P Mason, Michael Weller, René O Mirimanoff, J Gregory Cairncross. Oncologist 2006
278
30

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
Roel G W Verhaak, Katherine A Hoadley, Elizabeth Purdom, Victoria Wang, Yuan Qi, Matthew D Wilkerson, C Ryan Miller, Li Ding, Todd Golub, Jill P Mesirov,[...]. Cancer Cell 2010
30

Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations.
Cameron Brennan, Hiroyuki Momota, Dolores Hambardzumyan, Tatsuya Ozawa, Adesh Tandon, Alicia Pedraza, Eric Holland. PLoS One 2009
377
30

Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.
Sandeep Kunwar, Susan Chang, Manfred Westphal, Michael Vogelbaum, John Sampson, Gene Barnett, Mark Shaffrey, Zvi Ram, Joseph Piepmeier, Michael Prados,[...]. Neuro Oncol 2010
278
20


Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.
Edward R Laws, Ian F Parney, Wei Huang, Fred Anderson, Angel M Morris, Anthony Asher, Kevin O Lillehei, Mark Bernstein, Henry Brem, Andrew Sloan,[...]. J Neurosurg 2003
462
20

MGMT gene silencing and benefit from temozolomide in glioblastoma.
Monika E Hegi, Annie-Claire Diserens, Thierry Gorlia, Marie-France Hamou, Nicolas de Tribolet, Michael Weller, Johan M Kros, Johannes A Hainfellner, Warren Mason, Luigi Mariani,[...]. N Engl J Med 2005
20

Glioblastoma survival in the United States before and during the temozolomide era.
Derek R Johnson, Brian Patrick O'Neill. J Neurooncol 2012
480
20

Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas.
Justin S Smith, Edward F Chang, Kathleen R Lamborn, Susan M Chang, Michael D Prados, Soonmee Cha, Tarik Tihan, Scott Vandenberg, Michael W McDermott, Mitchel S Berger. J Clin Oncol 2008
763
20

Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients.
Shota Tanaka, Fredric B Meyer, Jan C Buckner, Joon H Uhm, Elizabeth S Yan, Ian F Parney. J Neurosurg 2013
70
20

IDH1 and IDH2 mutations in gliomas.
Hai Yan, D Williams Parsons, Genglin Jin, Roger McLendon, B Ahmed Rasheed, Weishi Yuan, Ivan Kos, Ines Batinic-Haberle, Siân Jones, Gregory J Riggins,[...]. N Engl J Med 2009
20

Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.
Sandeep Kunwar, Michael D Prados, Susan M Chang, Mitchel S Berger, Frederick F Lang, Joseph M Piepmeier, John H Sampson, Zvi Ram, Philip H Gutin, Robert D Gibbons,[...]. J Clin Oncol 2007
225
20


A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting.
E Antonio Chiocca, Khalid M Abbed, Stephen Tatter, David N Louis, Fred H Hochberg, Fred Barker, Jean Kracher, Stuart A Grossman, Joy D Fisher, Kathryn Carson,[...]. Mol Ther 2004
267
20

The art of gene therapy for glioma: a review of the challenging road to the bedside.
Alex Tobias, Atique Ahmed, Kyung-Sub Moon, Maciej S Lesniak. J Neurol Neurosurg Psychiatry 2013
77
20


Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide.
Gautam Prasad, Theo Sottero, Xiaodong Yang, Sabine Mueller, C David James, William A Weiss, Mei-Yin Polley, Tomoko Ozawa, Mitchel S Berger, Dana T Aftab,[...]. Neuro Oncol 2011
110
20

Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.
Lucia Ricci-Vitiani, Roberto Pallini, Mauro Biffoni, Matilde Todaro, Gloria Invernici, Tonia Cenci, Giulio Maira, Eugenio Agostino Parati, Giorgio Stassi, Luigi Maria Larocca,[...]. Nature 2010
888
20

AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study.
Arto Immonen, Matti Vapalahti, Kristiina Tyynelä, Heleena Hurskainen, Anu Sandmair, Ritva Vanninen, Gillian Langford, Neil Murray, Seppo Ylä-Herttuala. Mol Ther 2004
268
20

Cellular-based immunotherapies for patients with glioblastoma multiforme.
Xun Xu, Florian Stockhammer, Michael Schmitt. Clin Dev Immunol 2012
15
20

A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas.
Peter Forsyth, Gloria Roldán, David George, Carla Wallace, Cheryl Ann Palmer, Don Morris, Gregory Cairncross, Maureen Vallee Matthews, James Markert, Yancey Gillespie,[...]. Mol Ther 2008
179
20

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.
Heidi S Phillips, Samir Kharbanda, Ruihuan Chen, William F Forrest, Robert H Soriano, Thomas D Wu, Anjan Misra, Janice M Nigro, Howard Colman, Liliana Soroceanu,[...]. Cancer Cell 2006
20

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.
J Fueyo, C Gomez-Manzano, R Alemany, P S Lee, T J McDonnell, P Mitlianga, Y X Shi, V A Levin, W K Yung, A P Kyritsis. Oncogene 2000
555
20

The biology of VEGF and its receptors.
Napoleone Ferrara, Hans-Peter Gerber, Jennifer LeCouter. Nat Med 2003
20

Angiogenesis in malignant primary and metastatic brain tumors.
J C Reijneveld, E E Voest, M J Taphoorn. J Neurol 2000
48
20

Integrin alphavbeta3-targeted radioimmunotherapy of glioblastoma multiforme.
Anand Veeravagu, Zhaofei Liu, Gang Niu, Kai Chen, Bing Jia, Weibo Cai, Cunjing Jin, Andrew R Hsu, Andrew J Connolly, Victor Tse,[...]. Clin Cancer Res 2008
59
20

Recent developments on immunotherapy for brain cancer.
Derek A Wainwright, Pragati Nigam, Bart Thaci, Mahua Dey, Maciej S Lesniak. Expert Opin Emerg Drugs 2012
44
20

Targeted toxins in brain tumor therapy.
Yan Michael Li, Walter A Hall. Toxins (Basel) 2010
28
20

Gene therapy and targeted toxins for glioma.
Maria G Castro, Marianela Candolfi, Kurt Kroeger, Gwendalyn D King, James F Curtin, Kader Yagiz, Yohei Mineharu, Hikmat Assi, Mia Wibowo, A K M Ghulam Muhammad,[...]. Curr Gene Ther 2011
58
20

Thermal therapy of canine cerebral tumors using a 980 nm diode laser with MR temperature-sensitive imaging feedback.
Marko Kangasniemi, Roger J McNichols, James A Bankson, Ashok Gowda, Roger E Price, John D Hazle. Lasers Surg Med 2004
51
20

Stem cells as delivery vehicles for oncolytic adenoviral virotherapy.
Justin Kranzler, Matthew A Tyler, Adam M Sonabend, Ilya V Ulasov, Maciej S Lesniak. Curr Gene Ther 2009
13
20

Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
Timothy F Cloughesy, Patrick Y Wen, H Ian Robins, Susan M Chang, Morris D Groves, Karen L Fink, Larry Junck, David Schiff, Lauren Abrey, Mark R Gilbert,[...]. J Clin Oncol 2006
106
20

Perifosine and CCI 779 co-operate to induce cell death and decrease proliferation in PTEN-intact and PTEN-deficient PDGF-driven murine glioblastoma.
Kenneth L Pitter, Craig J Galbán, Stefanie Galbán, Omid Saeed Tehrani, Fei Li, Nikki Charles, Michelle S Bradbury, Oren J Becher, Thomas L Chenevert, Alnawaz Rehemtulla,[...]. PLoS One 2011
58
20

Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study.
Evanthia Galanis, Jan C Buckner, Matthew J Maurer, Jeffrey I Kreisberg, Karla Ballman, J Boni, Josep M Peralba, Robert B Jenkins, Shaker R Dakhil, Roscoe F Morton,[...]. J Clin Oncol 2005
543
20

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma.
John S Yu, Gentao Liu, Han Ying, William H Yong, Keith L Black, Christopher J Wheeler. Cancer Res 2004
379
20

HMGB1 mediates endogenous TLR2 activation and brain tumor regression.
James F Curtin, Naiyou Liu, Marianela Candolfi, Weidong Xiong, Hikmat Assi, Kader Yagiz, Matthew R Edwards, Kathrin S Michelsen, Kurt M Kroeger, Chunyan Liu,[...]. PLoS Med 2009
257
20

Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.
John H Sampson, Amy B Heimberger, Gary E Archer, Kenneth D Aldape, Allan H Friedman, Henry S Friedman, Mark R Gilbert, James E Herndon, Roger E McLendon, Duane A Mitchell,[...]. J Clin Oncol 2010
518
20

Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts.
Birgit Geoerger, Jacques Grill, Paule Opolon, Jackie Morizet, Geneviève Aubert, Marie-José Terrier-Lacombe, Brigitte Bressac De-Paillerets, Michel Barrois, Jean Feunteun, David H Kirn,[...]. Cancer Res 2002
86
20

The spectrum of vaccine therapies for patients with glioblastoma multiforme.
Laura K Aguilar, Mariel Arvizu, Estuardo Aguilar-Cordova, E Antonio Chiocca. Curr Treat Options Oncol 2012
17
20

Dendritic cell immunotherapy for malignant gliomas.
Anne Luptrawan, Gentao Liu, John S Yu. Rev Recent Clin Trials 2008
19
20



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.